Cover Image
市場調查報告書

中國的維他命產業分析

China Vitamin Industry Report, 2014-2017

出版商 ResearchInChina 商品編碼 270637
出版日期 內容資訊 英文 117 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的維他命產業分析 China Vitamin Industry Report, 2014-2017
出版日期: 2014年06月04日 內容資訊: 英文 117 Pages
簡介

中國為全球最大的維他命生產國,其中維他命C及E成為重要的產品。2009年之後,由於海外需求的低迷及價格下降,中國的維他命生產量,大幅降低。2013年的中國的各種維他命產品的生產量,與去年同期比較減少7.4%,成為約20萬1千噸。

本報告提供中國的維他命產業相關分析、全球整體的產業結構與趨勢、中國整體及各產品領域的產業趨勢(生產量、貿易量、價格水準等的實際成果值、預測值)、主要企業簡介(簡介、經營情形、收益結構、主要客戶、維他命產業、未來展望與預測)等調查,並將結果概述為以下內容。

第1章 維他命概要

  • 定義
  • 分類

第2章 中國的維他命產業趨勢

  • 國際市場
  • 目前發展情形
  • 競爭模式
  • 進出口
    • 出口
    • 進口
  • 今後預測與預測

第3章 維他命產業:各部門分析

  • 維他命A
    • 市場趨勢
    • 進出口
    • 市場價格
  • 維他命B
    • D-/DL-泛酸(維他命B3或維他命B5)
    • 維他命B6
    • 維他命B1
    • 維他命B2
    • 氯化膽鹼(維他命B4)
    • 維他命B12
  • 維他命C
    • 市場趨勢
    • 進出口
    • 市場價格
  • 維他命E
    • 市場趨勢
    • 進出口
    • 市場價格
  • 其他

第4章 主要企業

  • DSM
  • BASF
  • Adisseo
  • CSPC Pharmaceutical Group Limited
  • Shandong Xinhua Pharmaceutical
  • North China Pharmaceutical
  • PKU Healthcare
  • Zhejiang Medicine Co., Ltd.
  • Northeast Pharmaceutical
  • Hubei Guangji Pharmaceutical
  • NHU
  • Brother Enterprises Holding
  • Zhejiang Hangzhou Xinfu Pharmaceutical
  • Kingdomway
  • Henan Topfond Pharmaceutical Co.,Ltd
  • Xinfa Pharmaceutical

第5章 預測與前景

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: QJC008

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total output and vitamin E takes up about 30%. Since 2009, influenced by the sluggish external demand and declining prices, China's output of vitamin products has been declining sharply. In 2013, the output of various types of vitamin products in China was about 201,000 tons, down 7.4% YoY.

China is also the world's largest export base of vitamins, mainly vitamin C, vitamin E and pantothenic calcium. In 2013, China's export volume of vitamin C and vitamin E accounted for 55.0% and 23.7% of total export volume over the same period. In addition, the proportions of D or DL-pantothenic acid (i.e. vitamin B3 or B5) have increased to 5.7%.

Chinese vitamin producers fall into two types: large integrated pharmaceutical enterprises and professional vitamin producers. In 2009-2013, large integrated pharmaceutical enterprises such as North China Pharmaceutical Co.,Ltd and Northeast Pharmaceutical Group Co.,Ltd mostly had heavy burden historically and encountered operating difficulties and development obstacles, thus their ratio of R & D investment in total revenue was less than 3%; while professional vitamin producers like NHU, Kingdomway, and Brother Enterprises Holding kept higher gross margins of their products, with R & D investment generally accounting for more than 4% of revenue.

In recent years, the global and Chinese vitamin market has been exhibiting a monopolistic competition pattern. CSPC Pharmaceutical Group, North China Pharmaceutical, Northeast Pharmaceutical, Aland (Jiangsu) Nutraceutical, Shandong Luwei Pharmaceutical and other Chinese companies with production capacity of more than 15,000 tons, are the major suppliers in the global VC market. Zhejiang Medicine, NHU, and PKU Healthcare together shared about 50% of the global total capacity of VE. NHU, Zhejiang Medicine and Kingdomway three companies together accounted for 40%-50% of the global total capacity of VA.

Since the vitamin industry has high technical barriers, the existing major producers have already formed their own competitive advantages and the cost of quitting is high. So it is estimated that in 2014-2017, the monopolistic competition pattern in China vitamin industry will persist.

image1

"China Vitamin Industry Report, 2014-2017" provided by ResearchInChina covers the following:

  • China vitamin market supply and demand, import and export, competition pattern and development projections;
  • Development status, competition pattern, import and export, market prices of VC, VA, VB, VE products in China;
  • Operation, vitamin business and development prospects of 16 global and Chinese vitamin companies.

Table of Contents

1 Overview of Vitamins

  • 1.1 Definition
  • 1.2 Classification
  • 1.3 Global Overview

2 Development of China Vitamin Industry

  • 2.1 Status Quo
  • 2.2 Import and Export
    • 2.2.1 Export
    • 2.2.2 Import
  • 2.3 Competition Pattern

3 China Vitamin Market Segments

  • 3.1 VA
    • 3.1.1 Development Status
    • 3.1.2 Import and Export
    • 3.1.3 Market Price
  • 3.2 VB
    • 3.2.1 D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5)
    • 3.2.2 VB6
    • 3.2.3 VB1
    • 3.2.4 VB2
    • 3.2.5 Choline Chloride (VB4)
    • 3.2.6 VB12
  • 3.3 VC
    • 3.3.1 Development Status
    • 3.3.2 Import and Export
    • 3.3.3 Market Price
  • 3.4 VE
    • 3.4.1 Development Status
    • 3.4.2 Import and Export
    • 3.4.3 Market Price
  • 3.5 Others

4 Key Enterprises

  • 4.1 DSM
    • 4.1.1 Profile
    • 4.1.2 Operation
    • 4.1.3 Vitamin Business
    • 4.1.4 R&D
    • 4.1.5 Business in China
  • 4.2 BASF
    • 4.2.1 Profile
    • 4.2.2 Operation
    • 4.2.3 Vitamin Business
    • 4.2.4 Business in China
  • 4.3 Adisseo
    • 4.3.1 Profile
    • 4.3.2 Vitamin Business
    • 4.3.2 R & D
  • 4.4 CSPC Pharmaceutical Group Limited
    • 4.4.1 Profile
    • 4.4.2 Operation
    • 4.4.3 Revenue Structure
    • 4.4.4 Vitamin Business
    • 4.4.5 R & D
  • 4.5 Shandong Xinhua Pharmaceutical
    • 4.5.1 Profile
    • 4.5.2 Operation
    • 4.5.3 Revenue Structure
    • 4.5.4 Vitamin Business
    • 4.5.5 R & D
    • 4.5.6 Major Clients
  • 4.6 North China Pharmaceutical
    • 4.6.1 Profile
    • 4.6.2 Operation
    • 4.6.3 Revenue Structure
    • 4.5.4 Vitamin Business
    • 4.6.5 R & D
    • 4.6.6 Major Clients
  • 4.7 PKU Healthcare
    • 4.7.1 Profile
    • 4.7.2 Operation
    • 4.7.3 Revenue Structure
    • 4.7.4 Vitamin Business
    • 4.7.5 R & D
    • 4.7.6 Major Clients
  • 4.8 Zhejiang Medicine Co., Ltd.
    • 4.8.1 Profile
    • 4.8.2 Operation
    • 4.8.3 Revenue Structure
    • 4.8.4 Vitamin Business
    • 4.8.5 R & D
    • 4.8.6 Major Clients
  • 4.9 Northeast Pharmaceutical
    • 4.9.1 Profile
    • 4.9.2 Operation
    • 4.9.3 Revenue Structure
    • 4.9.4 Vitamin Business
    • 4.9.5 R & D
    • 4.9.6 Major Clients
  • 4.10 Hubei Guangji Pharmaceutical
    • 4.10.1 Profile
    • 4.10.2 Operation
    • 4.10.3 Revenue Structure
    • 4.10.4 Vitamin Business
    • 4.10.5 R & D
    • 4.10.6 Major Clients
  • 4.11 NHU
    • 4.11.1Profile
    • 4.11.2 Operation
    • 4.11.3 Revenue Structure
    • 4.11.4 Vitamin Business
    • 4.11.5 R & D
    • 4.11.6 Major Clients
  • 4.12 Brother Enterprises Holding
    • 4.12.1 Profile
    • 4.12.2 Operation
    • 4.12.3 Revenue Structure
    • 4.12.4 Vitamin Business
    • 4.12.5 R & D
    • 4.12.6 Major Clients
  • 4.13 Zhejiang Hangzhou Xinfu Pharmaceutical
    • 4.13.1 Profile
    • 4.13.2 Operation
    • 4.13.3 Revenue Structure
    • 4.13.4 Vitamin Business
    • 4.13.5 R & D
    • 4.13.6Major Clients
  • 4.14 Kingdomway
    • 4.14.1 Profile
    • 4.14.2 Operation
    • 4.14.3 Revenue Structure
    • 4.14.4 R & D
    • 4.14.5 Major Clients
  • 4.15 Henan Topfond Pharmaceutical Co.,Ltd
    • 4.15.1 Profile
    • 4.15.2 Operation
    • 4.15.3 Vitamin Business
    • 4.15.4 R & D
  • 4.16 Xinfa Pharmaceutical
    • 4.16.1 Profile
    • 4.16.2 Operation

5 Forecast and Outlook

  • 5.1 Output and Product Mix
  • 5.2 Competition Pattern

Selected Charts

  • Classification and Effect of Vitamins
  • Global Sales of Vitamin and Mineral Medicine, 2006-2013
  • Global Consumption Structure of Vitamins (by Application)
  • Global Consumption Structure of Major Vitamin Products (by Application)
  • Output of Vitamin Products in China, 2009-2013
  • Output Structure of Vitamin Products in China, 2012
  • China's Export Volume, Export Value and Average Export Price of Vitamins, 2009-2014
  • Structure of China's Vitamin Export Volume, by Product, 2008-2013
  • Export Destinations of China's Vitamins, 2013
  • China's Import Volume, Import Value and Import Average Price of Vitamins, 2010-2014
  • Structure of China's Vitamin Import Volume, by Product, 2008-2013
  • Import Sources of Vitamins in China, 2013
  • Major Vitamin A Enterprises and Their Output in China, 2011-2012
  • China's Export Volume of VA and YoY Growth, 2009-2014
  • China's Export Value of VA and YoY Growth, 2009-2014
  • Export Destinations of China's VA, 2013
  • China's Import Volume of VA and YoY Growth, 2009-2014
  • China's Import Value of VA and YoY Growth, 2009-2014
  • Import Sources of VA in China, 2013
  • Market Prices of VA in China, 2009-2014
  • China's Export Volume, Export Value and Export Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
  • China's Import Volume, Import Value and Import Average Price of D or DL-Pantothenic Acid (Vitamin B3 or Vitamin B5), 2009-2014
  • Market Prices of Calcium Pantothenate (VB5) in China, 2009-2014
  • Market Prices of Niacin (VB3) in China 2009-2014
  • China's Export Volume, Export Value and Export Price of VB6, 2009-2014
  • Market Price of VB6 in China, 2009-2014
  • Output and Export Volume of Major Vitamin B1 Producers in China, 2011-2012
  • China's Export Volume, Export Value and Export Price of VB1, 2009-2014
  • Market Price of VB1 in China, 2009-2014
  • Chinese Major Producers' Output and Export Volume of Vitamin B2 and Its Salts, 2012
  • China's Export Volume, Export Value and Export Price of VB2, 2009-2014
  • Market Prices of VB2 (80%) in China, 2009-2014
  • Structure (%) of China's Choline Chloride Exporting Countries, by Export Volume, 2010-2012
  • Market Prices of Choline Chloride (VB4) in China, 2009-2014
  • China's Export Volume, Export Value and Export Price of VB12, 2009-2014
  • Market Price of VB12 (Liquid Phase 1%) in China, 2009-2013
  • Major Vitamin C Enterprises and Their Output in China, 2012
  • China's Export Volume, Export Value and Export Price of VC, 2009-2014
  • Export Destinations of China's VC , 2013
  • China's Import Volume, Import Value and Import Price of VC, 2009-2014
  • Import Sources of VC in China, 2013
  • Market Price Trends of Coated VC in China, 2009-2014
  • Major VE Enterprises and Their Output in China, 2012
  • China's VE Export Volume and YoY Growth, 2009-2014
  • China's Export Value and Average Price of VE, 2009-2014
  • Export Destinations of China's VE, 2013
  • China's VE Import Volume and YoY Growth, 2009-2014
  • China's Import Value and Import Average Price of VE, 2009-2014
  • Import Sources of VE in China, 2013
  • Market Price Trends of VE in China, 2009-2014
  • China's Output, Export Volume and Growth of Minority Vitamins, 2011-2012
  • Sales and Net Income of DSM, 2009-2014
  • Major Businesses of DSM
  • Sales Structure of DSM, by Business, 2009-2013
  • Sales and EBITDA of DSM's Nutritional Business, 2009-2014
  • R & D Costs and % of Revenue of DSM, 2009-2013
  • DSM's Sales in China, 2009-2013
  • Sales and Net Income of BASF, 2009-2013
  • Sales, EBITDA and % in Revenue of BASF's Performance Products, 2009-2013
  • Sales of Adisseo, 2008-2012
  • Revenue and Net Income of CSPC, 2009-2013
  • Operating Revenue and Profit of CSPC, by Product, 2010-2012
  • Revenue Breakdown of CSPC, by Region, 2010-2013
  • Revenue Structure of CSPC, by Region, 2012-2013
  • CSPC's Output and Export Volume of Vitamins, by Product, 2012
  • CSPC's Revenue of VC Business, 2010-2013
  • Revenue and Net Income of Xinhua Pharmaceutical, 2008-2014
  • Operating Revenue Structure of Xinhua Pharmaceutical, by Product, 2008-2013
  • Revenue of Xinhua Pharmaceutical, by Product, 2008-2013
  • Xinhua Pharmaceutical's Gross Margin of Preparation Products, 2008-2013
  • R & D Costs and % in Revenue of Xinhua Pharmaceutical, 2010-2013
  • Xinhua Pharmaceutical's Revenue from Top 5 Clients and % in Total Revenue, 2008-2013
  • Revenue and Net Income of North China Pharmaceutical, 2008-2014
  • Operating Revenue Structure of North China Pharmaceutical, by Region, 2008-2013
  • Revenue of North China Pharmaceutical, by Region, 2008-2013
  • Operating Revenue Structure of North China Pharmaceutical, by Product, 2009-2013
  • Revenue of North China Pharmaceutical, by Product, 2009-2013
  • North China Pharmaceutical's Subsidiaries Engaging in Vitamin Business
  • North China Pharmaceutical's Output and Export Volume of Some APIs, 2012
  • North China Pharmaceutical's Gross Margin of Vitamin Products, 2008-2013
  • R & D Costs and % in Revenue of North China Pharmaceutical, 2008-2013
  • North China Pharmaceutical's Revenue from Top5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of PKU Healthcare, 2008-2014
  • Operating Revenue Structure of PKU Healthcare, by Region, 2008-2013
  • Revenue of PKU Healthcare, by Region, 2008-2013
  • Operating Revenue Structure of PKU Healthcare, by Sector, 2008-2013
  • Revenue of PKU Healthcare, by Sector, 2008-2013
  • Major Vitamin Products of PKU Healthcare
  • R & D Costs and % in Revenue of PKU Healthcare, 2011-2013
  • North China Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Zhejiang Medicine, 2009-2014
  • Operating Revenue Structure of Zhejiang Medicine, by Region, 2009-2013
  • Revenue of Zhejiang Medicine, by Region, 2009-2013
  • Operating Revenue Structure of Zhejiang Medicine, by Sector, 2009-2013
  • Revenue of Zhejiang Medicine, by Sector, 2009-2013
  • Zhejiang Medicine's Output and Export Volume of Some APIs, 2012
  • R & D Costs and % in Revenue of Zhejiang Medicine, 2009-2013
  • Zhejiang Medicine's Revenue from Top5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Northeast Pharmaceutical, 2009-2014
  • Operating Revenue Structure of Northeast Pharmaceutical, by Region, 2009-2013
  • Revenue of Northeast Pharmaceutical, by Region, 2009-2013
  • Operating Revenue Structure of Northeast Pharmaceutical, by Sector, 2009-2013
  • Revenue of Northeast Pharmaceutical, by Sector, 2009-2013
  • Northeast Pharmaceutical's Output and Export Volume of VC Products, 2011-2012
  • Expenditure for Development Project of Northeast Pharmaceutical, 2010-2013
  • Northeast Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Guangji Pharmaceutical, 2008-2014
  • Operating Revenue Structure of Guangji Pharmaceutical, by Region, 2008-2013
  • Revenue of Guangji Pharmaceutical, by Region, 2008-2013
  • Operating Revenue Structure of Guangji Pharmaceutical, by Sector, 2008-2013
  • Revenue of Guangji Pharmaceutical, by Sector, 2008-2013
  • Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2013
  • Net Income of Guangji Pharmaceutical's Subsidiaries Engaging in Vitamin Business, 2010-2013
  • Guangji Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of NHU, 2008-2014
  • Operating Revenue Structure of NHU, by Region, 2008-2013
  • Revenue of NHU, by Region, 2008-2013
  • Operating Revenue Structure of NHU, by Sector, 2008-2013
  • Revenue of NHU, by Sector, 2008-2011
  • Operating Revenue Structure of NHU, by Sector, 2012-2013
  • Revenue of NHU, by Sector, 2012-2013
  • NHU's Subsidiaries Engaging in Vitamin Business
  • Net Income of NHU's Subsidiaries Engaging in Vitamin Business, 2009-2013
  • NHU's Gross Margin of Vitamin Products, 2008-2011
  • NHU's Gross Margin of Vitamin Products, 2011-2013
  • R & D Costs and % in Revenue of NHU, 2009-2013
  • NHU's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Brother, 2008-2014
  • Operating Revenue Structure of Brother, by Region, 2008-2013
  • Revenue of Brother, by Region, 2008-2013
  • Operating Revenue Structure of Brother, by Product, 2008-2013
  • Revenue of Brother, by Product, 2008-2013
  • Brother's Gross Margin of Vitamin Products, 2008-2013
  • R & D Costs and % in Revenue of Brother, 2008-2013
  • Brother's Revenue from Top 5 Clients and % of Total Revenue, 2008-2013
  • Revenue and Net Income of Xinfu Pharmaceutical, 2009-2014
  • Operating Revenue Structure of Xinfu Pharmaceutical, by Region, 2009-2013
  • Revenue of Xinfu Pharmaceutical, by Region, 2009-2013
  • Operating Revenue Structure of Xinfu Pharmaceutical, by Product, 2009-2013
  • Revenue of Xinfu Pharmaceutical, by Product, 2009-2013
  • Xinfu Pharmaceutical's Gross Margin of Vitamin Products, 2009-2013
  • R & D Costs and % in Revenue of Xinfu Pharmaceutical, 2009-2013
  • Xinfu Pharmaceutical's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Kingdomway, 2009-2014
  • Operating Revenue Structure of Kingdomway, by Region, 2009-2013
  • Revenue of Kingdomway, by Region, 2009-2013
  • Operating Revenue Structure of Kingdomway, by Product, 2009-2013
  • Revenue of Kingdomway, by Product, 2009-2013
  • Kingdomway's Gross Margin of Vitamin Related Products, 2009-2013
  • R & D Costs and % in Revenue of Kingdomway, 2009-2013
  • Kingdomway's Revenue from Top 5 Clients and % of Total Revenue, 2009-2013
  • Revenue and Net Income of Topfond Pharmaceutical, 2008-2011
  • Xinfa Pharmaceutical's Vitamin Products, Applications and Technical Standards
  • China's Output of Vitamin Products, 2013-2017E

Related Companies

  • China Pharmaceutical Group Limited(01093.HK)
  • Shandong Xinhua Pharmaceutical Company Limited(000756.SZ)
  • North China Pharmaceutical Co.,Ltd.(600812.SH)
  • PKU International Healthcare Group Southwest Pharmaceutical Co., Ltd.(000788.SZ)
  • Zhejiang Medicine Co.,Ltd.(600216.SH)
  • Northeast Pharmaceutical Group Co.,Ltd.(000597.SZ)
  • Hubei Guangji Pharmaceutical Co.,Ltd.(000952.SZ)
  • Zhejiang NHU Company Ltd.(002001.SZ)
  • Brother Enterprises Holding Co.,Ltd(002562.SZ)
  • Zhejiang Hangzhou Xinfu Pharmaceutical Co.,Ltd.(002019.SZ)
  • Xiamen Kingdomway Group Company(002626.SZ)
Back to Top